Onglyza

In the US, Onglyza (saxagliptin systemic) is a member of the drug class dipeptidyl peptidase 4 inhibitors and is used to treat Diabetes, Type 2.

US matches:

• Onglyza

UK matches:

• Onglyza 5mg film-coated tablets (SPC)

Ingredient matches for Onglyza

Saxagliptin

Saxagliptin hydrochloride (a derivative of Saxagliptin) is reported as an ingredient of Onglyza in the following countries:

• Belgium


• Germany


• Greece


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.